Journal

EvidenceMD free and paid pricing checked in October 2026, plus worked examples for comparing usage, annual commitments and verified workflow costs.

How UK doctors can compare EvidenceMD alternatives by evidence lookup, source access, medical learning and documentation needs, including where iatroX fits.

A workflow-led comparison of EvidenceMD and iatroX for UK clinicians, covering referenced answers, medical learning, source checking and a fair trial.

Improve MRCPCH AKP diagnostic reasoning by comparing plausible alternatives, identifying discriminating findings and explaining the whole clinical pattern.

Four original UKMLA chest-pain cases show how urgency, symptom pattern and clinical probability change the next investigation or immediate action.

Three plausible futures for a doctor's AI toolkit: one integrated suite, modular specialist services or a hybrid. The outcome depends on evidence, interoperability and clinician ch...

Supplier nationality, CE conformity, hosting and clinical quality are different questions. A practical framework for comparing European, British and American medical AI.

Europe's opportunity may lie in repeatable clinical value rather than winning every model benchmark. The business case depends on localisation, deployment economics and retention.

The strategic bottleneck in healthcare AI may be access to clinical work rather than the underlying model. Examine distribution, switching costs, open interfaces and procurement ch...

Three scenarios for clinical AI competition after indefinite CE recognition: broader choice, stronger integrated platforms or slower adoption despite easier market access.

Tandem's broader clinical platform creates real competitive pressure. Specialist tools need depth, direct clinician value and evidence of continued usefulness, not comforting categ...

A shared clinical AI interface can contain functions with different purposes and risks. Tandem's expanding suite shows why product boundaries and change control matter.